Trajectoire type : Poids dpart : 92 kg Phase 1 (12 mois Wegovy) : -16 kg 76 kg (17% perte) Arrt traitement (contrainte budgtaire) Phase 2 (12 mois post-arrt) : +10 kg 86 kg Pattern observ (donnes STEP 4 bras placebo) : Mois 1-3 post-arrt : Poids stable Mois 4-6 : Retour apptit progressif Mois 7-12 : Regain acclr (fringales, portions augmentes) Regain mdian : 62,5% du poids perdu (10 kg sur 16 kg) Leon STEP 4 : Wegovy = traitement chronique
Instead, its a delicate, white puck or loose powder at the bottom of a vacuum-sealed glass vial
Patients with a history of hepatic disease require heightened surveillance and cautious dose adjustment
Minimal Vascular Interruption: Unlike intravenous injections, IM injections do not require venous access, which can be a significant advantage for patients with complex or compromised vein access
Lab work is not required to get started either
[2] Another peptide, Ipamorelin, is similar to GHRP but often preferred for its milder effects